International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
نویسندگان
چکیده
New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.
منابع مشابه
Anti-phospholipid/Cofactor Antibodies
Following a meeting at Sapporo, Japan, an international consensus statement on preliminary classification criteria for definite anti-phospholipid syndrome was published.1 This set of criteria is divided into the clinical part which includes vascular thrombosis and pregnancy morbidity and the laboratory part which includes anti-cardiolipin (aCL) antibody and lupus anti-coagulant tests. Diagnosis...
متن کاملSubsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
PURPOSE International consensus criteria for antiphospholipid syndrome (APS) require persistently positive antiphospholipid antibodies (aPL) and medium or high titers in association with clinical manifestations. However, the clinical relevance of persistence and titers of aPL in patients with stroke has not been identified. We aimed to investigate the risk of subsequent thrombotic events in pat...
متن کاملClinical Management of Antiphospholipid Syndrome-Related Thrombosis
There is evidence that the presence of antiphospholipid antibodies is related with an increased risk of thrombotic events. Patients with definite antiphospholipid syndrome (APS) and a first venous event should receive long term oral anticoagulation to an international normalized ratio (INR) of 2.0-3.0. In patients with definite APS and arterial or recurrent thrombosis oral anticoagulation to an...
متن کاملAntiphospholipid antibody syndrome.
The 2006 International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome has increased the time between the two laboratory studies required for diagnosis from 6 to 12 weeks. Antibody to beta2 glycoprotein 1 has been included as a criterion. Various non-criteria diagnostic clues such as livedo reticularis, heart valve disease, thrombocytopenia...
متن کاملDiagnosis of antiphospholipid syndrome in routine clinical practice
The updated international consensus criteria for definite antiphospholipid syndrome (APS) are useful for scientific clinical studies. However, there remains a need for diagnostic criteria for routine clinical use. We audited the results of routine antiphospholipid antibodies (aPLs) in a cohort of 193 consecutive patients with aPL positivity-based testing for lupus anticoagulant (LA), IgG and Ig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of thrombosis and haemostasis : JTH
دوره 4 2 شماره
صفحات -
تاریخ انتشار 2006